BE539644A - - Google Patents
Info
- Publication number
- BE539644A BE539644A BE539644DA BE539644A BE 539644 A BE539644 A BE 539644A BE 539644D A BE539644D A BE 539644DA BE 539644 A BE539644 A BE 539644A
- Authority
- BE
- Belgium
- Prior art keywords
- antibiotic
- tetracycline
- magnesium chloride
- water
- class
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 56
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 53
- 230000003115 biocidal Effects 0.000 claims description 46
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000003242 anti bacterial agent Substances 0.000 claims description 22
- 150000003522 tetracyclines Chemical class 0.000 claims description 21
- 239000007924 injection Substances 0.000 claims description 18
- 238000002347 injection Methods 0.000 claims description 14
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 claims description 8
- 238000007918 intramuscular administration Methods 0.000 claims description 8
- 150000007524 organic acids Chemical class 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 229960002180 Tetracycline Drugs 0.000 claims description 7
- 239000004098 Tetracycline Substances 0.000 claims description 7
- 235000019364 tetracycline Nutrition 0.000 claims description 7
- 239000003589 local anesthetic agent Substances 0.000 claims description 6
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 claims description 5
- 229960004475 Chlortetracycline Drugs 0.000 claims description 5
- 239000004099 Chlortetracycline Substances 0.000 claims description 5
- 229960000625 Oxytetracycline Drugs 0.000 claims description 5
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims description 5
- 239000004100 Oxytetracycline Substances 0.000 claims description 5
- 235000019365 chlortetracycline Nutrition 0.000 claims description 5
- 235000019366 oxytetracycline Nutrition 0.000 claims description 5
- 230000003444 anaesthetic Effects 0.000 claims description 3
- 230000001225 therapeutic Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims 5
- 230000003000 nontoxic Effects 0.000 claims 3
- 231100000252 nontoxic Toxicity 0.000 claims 3
- 229960002337 magnesium chloride Drugs 0.000 description 21
- 239000000463 material Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000000725 suspension Substances 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- YCIHPQHVWDULOY-FMZCEJRJSA-N (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O YCIHPQHVWDULOY-FMZCEJRJSA-N 0.000 description 8
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 8
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 7
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 7
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 7
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 7
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 7
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 229940079866 intestinal antibiotics Drugs 0.000 description 7
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000007927 intramuscular injection Substances 0.000 description 6
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 5
- 229960001309 Procaine hydrochloride Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229940093915 Gynecological Organic acids Drugs 0.000 description 4
- 210000003205 Muscles Anatomy 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910052751 metal Chemical class 0.000 description 4
- 239000002184 metal Chemical class 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- DARFZFVWKREYJJ-UHFFFAOYSA-L magnesium;dichloride;dihydrate Chemical compound O.O.[Mg+2].[Cl-].[Cl-] DARFZFVWKREYJJ-UHFFFAOYSA-L 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229940050906 Magnesium chloride hexahydrate Drugs 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- -1 derivatives Chemical class 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000002035 prolonged Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- IMLJLCJZQLGHJS-JEKSYDDFSA-N (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;dihydrate Chemical compound O.O.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O IMLJLCJZQLGHJS-JEKSYDDFSA-N 0.000 description 1
- SVDOODSCHVSYEK-IFLJXUKPSA-N (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydron;chloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O SVDOODSCHVSYEK-IFLJXUKPSA-N 0.000 description 1
- QYAPHLRPFNSDNH-LYNLVHCPSA-N (4S,4aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)C3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-LYNLVHCPSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N 2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydron;chloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 229960003185 Chlortetracycline Hydrochloride Drugs 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- 229950002441 Glucurolactone Drugs 0.000 description 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N Glucuronolactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 229960000448 Lactic acid Drugs 0.000 description 1
- 210000003141 Lower Extremity Anatomy 0.000 description 1
- 229940091250 Magnesium supplements Drugs 0.000 description 1
- LEROTMJVBFSIMP-UHFFFAOYSA-N Mebutamate Chemical compound NC(=O)OCC(C)(C(C)CC)COC(N)=O LEROTMJVBFSIMP-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229960003924 Oxytetracycline Dihydrate Drugs 0.000 description 1
- 229960004368 Oxytetracycline Hydrochloride Drugs 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229960002494 Tetracaine hydrochloride Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 230000003139 buffering Effects 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229940053049 glucuronolactone Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001698 pyrogenic Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE539644A true BE539644A (da) |
Family
ID=169280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE539644D BE539644A (da) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE539644A (da) |
-
0
- BE BE539644D patent/BE539644A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2150576C (fr) | Compositions injectables a base de derives des taxanes | |
| CH630260A5 (fr) | Compositions antibiotiques a base d'une tetracycline. | |
| HU230439B1 (hu) | Legalább egy retinoidot és benzoil-peroxidot tartalmazó gél | |
| FR2914188A1 (fr) | Nouvelle composition a base d'oxime de cholest-4-en-3-one | |
| FR2480603A1 (fr) | Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine | |
| CH644015A5 (fr) | Solution aqueuse injectable a base d'oxytetracycline. | |
| BE539644A (da) | ||
| JPS6241645B2 (da) | ||
| FR2494115A1 (fr) | Preparation pharmaceutique pour le traitement des infections bacteriennes des animaux, contenant un sel ou derive halogeno-6b penicillanique et un ou plusieurs antibiotiques de type b-lactame | |
| FR2862063A1 (fr) | Agent gelifiant pour une huile | |
| JPS5914004B2 (ja) | アモキシシリン三水化物を含有する注射用医薬組成物 | |
| BE507692A (fr) | Perfectionnements apportés aux procedés de préparation de produits thérapeutiques | |
| BE1004051A4 (fr) | Solution injectable et procede pour la preparer. | |
| US3728452A (en) | Water-soluble composition comprising sulfadimidine and pyrimethamine | |
| AU675553B2 (en) | Intramuscular and subcutaneous injection solution for anianimals | |
| JP3131385B2 (ja) | 易吸収性カルシウムを含有する組成物およびその製造方法 | |
| US3170836A (en) | Injectable compositions comprising a copper-containing chelate complex compound dispersed in a stabilized oil-in-water emulsion and method of using the same | |
| EP0356325B1 (fr) | Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glycéride gélifié par au moins un polymère cellulosique | |
| EP0575481A1 (fr) | Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4. | |
| CA1221635A (fr) | Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires | |
| JPS5857407B2 (ja) | 直腸投与剤用基剤 | |
| JP2829261B2 (ja) | 家畜のビタミンｅ・セレン欠乏症に適用する注射剤 | |
| JPS6042322A (ja) | 新規な乳化製剤 | |
| JPH11501633A (ja) | 抗酸化性を有する医薬品、化粧品及び／または食品組成物 | |
| BE505709A (da) |